Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug
Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3…
Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug
Jazz Pharmaceuticals’ dordaviprone, brand name Modeyso, is now the first FDA-approved therapy for recurrent H3 K27M-mutant diffuse midline glioma. The drug came from Jazz’s $935 million acquisition of Chimerix earlier this year. The post Rare and Aggressive Brain Cancer Affecting Children Gets Its First FDA-Approved Drug appeared first on MedCity News.
Minors’ Ability to Consent to Contraception and Abortion Services
This brief examines state consent requirements for minors accessing contraceptive and abortion care, processes for minors to attempt to obtain abortion without parental involvement, and trends in state policy increasing requirements for parental involvement in minors’ health care decisions.
KFF Health News’ ‘What the Health?’: Kennedy Cancels Vaccine Funding
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…
Debunked Episode 18: Unpacking MAHA, Nutrition on a Regional and Global Scale
The Trump administration’s Make America Healthy Again nutrition policies and Medicare Advantage plan ethics were prominent themes on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and guest co-host Paul Markovich, CEO of Blue Shield of California parent company Ascendiun. The post Debunked Episode 18: Unpacking MAHA, Nutrition on a…
Ami Parekh & Ankoor Shah, Included Health
Ami Parekh is the Chief Health Officer & Ankoor Shah, is VP, Clinical Excellence at Included Health. I had a long conversation with them about the philosophy of how we are doing population health and how we fix the system that we have today. I’m arguing for more primary care, but Ami restated it and…
Centralized Data Aggregation in Homecare Powers Interoperability and Client-Centered Care
Centralized data aggregation is a necessity for homecare providers looking to address fragmentation, improve outcomes, and stay competitive in the rapidly evolving landscape. The path forward requires investment in tools that collect and transform data into actionable information. The post Centralized Data Aggregation in Homecare Powers Interoperability and Client-Centered Care appeared first on MedCity News.
The Top Appointment Scheduling Software for Wellness Clinics
[Sponsored] Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform. The post The Top Appointment Scheduling Software for Wellness Clinics appeared first on MedCity News.
Prior Authorization Process Policies in Medicaid Managed Care: Findings from a Survey of State Medicaid Programs
This brief examines state policies related to prior authorization processes in Medicaid managed care and includes findings about how states approach prior authorization decision timeframes, electronic denial notices, and access to external medical reviews, all as of July 1, 2024.
The Next Big Breakthroughs in Migraine Won’t Be Pills
In the current phase of evolution, next-generation digital services and treatments that allow better understanding of migraine triggers, the freedom of on-demand preventative action, and pain relief are emerging as migraine game-changers. The post The Next Big Breakthroughs in Migraine Won’t Be Pills appeared first on MedCity News.
KFF Health Information and Trust Tracking Poll: Health Information and Advice on Social Media
KFF’s Tracking Poll on Health Information and Trust finds that just over half of adults use social media for health information and advice at least occasionally but fewer than half say they find “most” or “some” of the information they see on each platform trustworthy.
